Questcor Pharma Profit Surges; Stock Up 9% - Quick Facts

(RTTNews) - Questcor Pharmaceuticals Inc. (QCOR) Tuesday reported second-quarter net income of $69 million or $1.12 per share, compared with $42 million or $0.65 per share last year.

Excluding items, adjusted earnings for the quarter were $83 million or $1.35 per share, compared with $44 million or $0.69 per share a year ago.

Revenues for the quarter surged to $185 million from $113 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $1.00 per share on revenues of $168.98 million for the quarter. Analysts' estimates typically exclude special items.

Growth was led mainly by the expanded usage of H.P. Acthar Gel (repository corticotropin injection) by rheumatologists, the company said.

Questcor shipped 7,050 vials of Acthar during the quarter, up 50 percent from last year.

Shares of the company gained 9.52% at $56.85 in after-hours trade on the Nasdaq.